Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
Recruiting
N/A
Interventional Study
Degenerative Mitral Valve Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 338 (estimated)
- Sponsor
- Sheng Liu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with chronic primary degenerative mitral regurgitation by the preoperative echocardiogram.
* Informed consent was obtained
Exclusion Criteria:
* Re-operation of mitral regurgitation
* Concurrent surgical plan for congenital heart disease, coronary artery bypass gra…
Contacts
No contact information available.